Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F13A1 | P00488 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | SCD | O00767 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2477399 | 1.00 | F13A1 (0.47) | F13A1MAPTRXFP1LMNATSHR | |
| SCHEMBL27641655 | 1.00 | F13A1 (0.47) | F13A1MAPTRXFP1LMNATSHR | |
| SCHEMBL31261412 | 1.00 | F13A1 (0.47) | F13A1MAPTRXFP1LMNATSHR | |
| SCHEMBL9533116 | 1.00 | F13A1 (0.47) | F13A1MAPTRXFP1LMNATSHR | |
| SCHEMBL28343241 | 0.98 | ALDH1A1 (0.44) | F13A1MAPTRXFP1LMNATSHR | |
| SCHEMBL11801847 | 0.95 | ALDH1A1 (0.49) | F13A1MAPTRXFP1LMNATSHR | |
| SCHEMBL7150330 | 0.95 | ALDH1A1 (0.49) | F13A1MAPTRXFP1LMNATSHR | |
| SCHEMBL988106 | 0.93 | ALDH1A1 (0.50) | MAPTLMNANFKB1ALDH1A1MEN1 | |
| SCHEMBL12132006 | 0.92 | ALDH1A1 (0.49) | MAPTLMNANFKB1ALDH1A1MEN1 | |
| SCHEMBL987088 | 0.87 | ALDH1A1 (0.55) | MAPTLMNANFKB1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090209485-A1 | MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES | PARISH CHRISTOPHER RICHARD | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209485-A1 | MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES | FLT4, UGGT1, FLT1 | F13A1 842/4885MAPT 4721/4885RXFP1 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.